DIANABOLOS Pharmaceutical at a Glance
DIANABOLOS Pharmaceutical is a methandienone research chemical formulated for in-vitro laboratory applications investigating anabolic steroid pathways. Manufactured by PHARMAQO, this compound represents one of the most extensively studied oral anabolic steroids in scientific literature. Researchers at Stroid UK Shop have utilised methandienone to examine androgen receptor binding mechanisms and anabolic signalling cascades since the compound’s first synthesis in 1958.
The methandienone molecule features a modified testosterone structure with methylation at the 17α position and double bond addition between carbons 1 and 2. These structural modifications enhance oral bioavailability in research models while maintaining significant androgenic activity. Laboratory studies demonstrate that methandienone exhibits approximately 40-60% of testosterone’s androgenic potency whilst showing enhanced anabolic properties in cellular assays. Research teams investigating methandienone tablet formulations have documented extensive protein synthesis modulation and nitrogen retention effects in controlled experimental conditions.
Laboratory Applications
Scientific investigations utilising DIANABOLOS focus on several key research areas within steroid biochemistry. Cellular studies examine methandienone’s interaction with androgen receptor complexes and subsequent transcriptional activity modulation. Researchers analyse the compound’s effects on myofibrillar protein synthesis pathways, particularly investigating mTOR signalling cascade activation in muscle cell cultures. Additionally, laboratory teams study methandienone’s influence on glycogenolysis and gluconeogenesis processes, evaluating metabolic pathway alterations in hepatic cell lines.
Comparative studies between methandienone and other anabolic compounds available through selective androgen receptor modulators demonstrate distinct receptor binding profiles and tissue selectivity patterns. Research applications also extend to investigating potential synergistic effects when combined with peptide research compounds in multi-factorial experimental designs. Pharmacokinetic studies examine methandienone’s absorption, distribution, and metabolism characteristics in various research models.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Methandienone |
| Manufacturer | PHARMAQO |
| CAS Registry | 72-63-9 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Molecular Weight | 300.44 g/mol |
| Storage Requirements | Room temperature, dry environment |
| Research Applications | Androgen receptor studies, protein synthesis research |
Research Compliance
This product is manufactured exclusively for in-vitro research applications and scientific investigation purposes. DIANABOLOS Pharmaceutical is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate safety protocols and regulatory compliance within their institutional frameworks.
